NASDAQ:ALTS ALT5 Sigma (ALTS) Stock Price, News & Analysis $6.57 +1.06 (+19.24%) Closing price 08/22/2025 04:00 PM EasternExtended Trading$7.36 +0.79 (+12.09%) As of 08/22/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About ALT5 Sigma Stock (NASDAQ:ALTS) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get ALT5 Sigma alerts:Sign Up Key Stats Today's Range$5.50▼$6.6950-Day Range$5.48▼$9.8752-Week Range$1.55▼$10.95Volume13.00 million shsAverage Volume9.27 million shsMarket Capitalization$141.98 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview ALT5 Sigma Corp. is a clinical-stage biopharmaceutical company, which engages in identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the large unmet medical need for the treatment of pain and addiction. It operates under the Biotechnology and Recycling segments. The Biotechnology segment focuses on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties. The Recycling segment is involved in a turnkey appliance recycling program. The company was founded by Edward R. Cameron in 1976 and is headquartered in Las Vegas, NV. Read More ALT5 Sigma Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks11th Percentile Overall ScoreALTS MarketRank™: ALT5 Sigma scored higher than 11% of companies evaluated by MarketBeat, and ranked 892nd out of 924 stocks in the finance sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for ALT5 Sigma. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Book Value per Share RatioALT5 Sigma has a P/B Ratio of 11.95. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted5.58% of the float of ALT5 Sigma has been sold short.Short Interest Ratio / Days to CoverALT5 Sigma has a short interest ratio ("days to cover") of 0.7, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in ALT5 Sigma has recently decreased by 15.63%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldALT5 Sigma does not currently pay a dividend.Dividend GrowthALT5 Sigma does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted5.58% of the float of ALT5 Sigma has been sold short.Short Interest Ratio / Days to CoverALT5 Sigma has a short interest ratio ("days to cover") of 0.7, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in ALT5 Sigma has recently decreased by 15.63%, indicating that investor sentiment is improving significantly. News and Social Media2.8 / 5News Sentiment0.00 News SentimentALT5 Sigma has a news sentiment score of 0.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.05 average news sentiment score of Finance companies.News Coverage This WeekMarketBeat has tracked 6 news articles for ALT5 Sigma this week, compared to 0 articles on an average week.Search Interest23 people have searched for ALTS on MarketBeat in the last 30 days. MarketBeat Follows9 people have added ALT5 Sigma to their MarketBeat watchlist in the last 30 days. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, ALT5 Sigma insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 4.90% of the stock of ALT5 Sigma is held by insiders.Percentage Held by InstitutionsOnly 6.27% of the stock of ALT5 Sigma is held by institutions.Read more about ALT5 Sigma's insider trading history. Receive ALTS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ALT5 Sigma and its competitors with MarketBeat's FREE daily newsletter. Email Address ALTS Stock News HeadlinesALT5 Sigma Corp. (ALTS) Stock Price Today - WSJAugust 23 at 5:37 PM | wsj.comTrump-linked crypto company ALT5 Sigma denies SEC investigation rumorsAugust 20, 2025 | msn.com[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the quiet buildup behind the scenes. Now, in just days, the floodgates are set to open. The greatest investor of all time could validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent — and four tiny miners could be your ticket to 100X gains.August 24 at 2:00 AM | Golden Portfolio (Ad)ALT5 Sigma Denies SEC Probe, Distances Itself From Jon IsaacAugust 20, 2025 | msn.comTrump’s $1.5B Crypto Partner Alt5 Sigma Reportedly Faces SEC Probe: What It Means for InvestorsAugust 19, 2025 | msn.comALT5 Sigma Second Quarter 2025 Earnings: US$0.30 loss per share (vs US$0.12 profit in 2Q 2024)August 19, 2025 | finance.yahoo.comALT5 Sigma Completes $1.5 Billion Direct OfferingAugust 18, 2025 | tipranks.comTraders Purchase Large Volume of ALT5 Sigma Call Options (NASDAQ:ALTS)August 16, 2025 | americanbankingnews.comSee More Headlines ALTS Stock Analysis - Frequently Asked Questions How have ALTS shares performed this year? ALT5 Sigma's stock was trading at $4.65 at the start of the year. Since then, ALTS shares have increased by 41.3% and is now trading at $6.57. Who are ALT5 Sigma's major shareholders? Top institutional shareholders of ALT5 Sigma include Geode Capital Management LLC (0.97%), Jane Street Group LLC (0.24%), Bridgeway Capital Management LLC (0.09%) and Evernest Financial Advisors LLC (0.07%). Insiders that own company stock include Peter Tassiopoulos and Virland A Johnson. View institutional ownership trends. How do I buy shares of ALT5 Sigma? Shares of ALTS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of ALT5 Sigma own? Based on aggregate information from My MarketBeat watchlists, some other companies that ALT5 Sigma investors own include JIADE (JDZG), Hyzon Motors (HYZN), New Horizon Aircraft (HOVR), Hour Loop (HOUR), Gossamer Bio (GOSS), Genius Group (GNS) and Ford Motor (F). Company Calendar Today8/24/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorFinance Industry FIN - MISC SVCS Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:ALTS Previous SymbolNASDAQ:ALTS CIK862861 WebN/A Phone(702) 997-5968Fax952-930-1800Employees170Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$6.24 million Net Margins-74.89% Pretax Margin-61.99% Return on Equity-179.27% Return on Assets-16.28% Debt Debt-to-Equity Ratio1.45 Current Ratio0.88 Quick Ratio0.88 Sales & Book Value Annual Sales$12.53 million Price / Sales11.33 Cash FlowN/A Price / Cash FlowN/A Book Value$0.55 per share Price / Book11.95Miscellaneous Outstanding Shares21,610,000Free Float20,550,000Market Cap$141.98 million OptionableN/A Beta2.17 The 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report This page (NASDAQ:ALTS) was last updated on 8/24/2025 by MarketBeat.com Staff From Our Partners[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredOne tiny company just cracked Google’s $19B problemAn MIT lab recently cracked a code scientists had been chasing for decades… Turning a “miracle metal” from ...True Market Insiders | SponsoredIs This Stock the 'Next Nvidia'?'AI Bottleneck' Now Threatens Entire Magnificent 7 A new critical failure has appeared in the AI market, an...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ALT5 Sigma Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share ALT5 Sigma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.